Clinical Trial Update: Effects of Intravenous K201 on the Restoration of Sinus Rhythm in Subjects With Symptomatic Atrial Fibrillation [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intravenous K201 for restoration of sinus rhythm in subjects with symptomatic atrial fibrillation was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• K201

Snippet

Sponsor: Sequel Pharmaceuticals, Inc | Conditions: Atrial Fibrillation | Phase 2 | Status: TERMINATED